{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:19:35Z","timestamp":1762298375645,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cca.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T01:56:43Z","timestamp":1459303003000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction"],"prefix":"10.1016","volume":"457","author":[{"given":"Li-Fen","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng-Hung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Mei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.03.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035310","article-title":"Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-study","volume":"7","author":"Pabst","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2016.03.012_bb0010","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00259-009-1165-2","article-title":"Prognostic risk stratification of myocardial ischemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease","volume":"36","author":"Hatta","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.cca.2016.03.012_bb0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5114\/aoms.2013.39792","article-title":"Treatment of non-ST- elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease","volume":"9","author":"Franczyk-Sk\u00f3ra","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cca.2016.03.012_bb0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5114\/aoms.2013.35424","article-title":"GREACE study collaborative group. Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study","volume":"9","author":"Athyros","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.cca.2016.03.012_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/hrt.2009.184879","article-title":"Arterial stiffness in chronic kidney disease: causes and consequences","volume":"96","author":"Chue","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.cca.2016.03.012_bb0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.03.012_bb0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1525-139X.2009.00576.x","article-title":"Protein-bound toxins: update 2009","volume":"22","author":"Jourde-Chiche","year":"2009","journal-title":"Semin. Dial."},{"key":"10.1016\/j.cca.2016.03.012_bb0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2010.03.036","article-title":"Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure","volume":"211","author":"Wang","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2016.03.012_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5301\/jn.5000111","article-title":"Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events","volume":"26","author":"Wang","year":"2013","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cca.2016.03.012_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2014.07.002","article-title":"Serum total p-cresylsulfate level is associated with abnormal QTc interval in stable angina patients with early stage of renal failure","volume":"437","author":"Tang","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2016.03.012_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","author":"Manjunath","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2006.08.042","article-title":"Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1590\/S0066-782X2007000600004","article-title":"Prognostic value of left atrial volume index in hemodialysis patients","volume":"88","author":"Barberato","year":"2007","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1388-9842(99)00057-4","article-title":"Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it?","volume":"1","author":"Dyadyk","year":"1999","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cca.2016.03.012_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.92","article-title":"p-Cresyl sulfate, a uremic toxin, causes vascular endothelial and smooth muscle cell damages by inducing oxidative stress","volume":"3","author":"Watanabe","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.cca.2016.03.012_bb0085","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jacc.2010.11.002","volume":"57","author":"American College of Cardiology Foundation Appropriate Use Criteria Task F","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0095","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.99.21.2829","volume":"99","author":"Gibbons","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2016.03.012_bb0100","first-page":"932","volume":"312","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2016.03.012_bb0105","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction","volume":"50","author":"Thygesen","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0110","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.05.007","volume":"52","author":"Bonow","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/dmrr.2426","article-title":"Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus","volume":"29","author":"Lu","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2016.03.012_bb0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/ndt\/gfs491","article-title":"Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population","volume":"28","author":"Kong","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2016.03.012_bb0130","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcin.2011.05.022","article-title":"Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention","volume":"4","author":"Hanna","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.cca.2016.03.012_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mje.2002.121536","volume":"15","author":"Gardin","year":"2002","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.cca.2016.03.012_bb0140","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCULATIONAHA.106.661983","article-title":"Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study","volume":"116","author":"Kasner","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2016.03.012_bb0145","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","article-title":"Defining diastolic heart failure: a call for standardized diagnostic criteria","volume":"101","author":"Vasan","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2016.03.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001852","article-title":"p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes","volume":"4","author":"Han","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2016.03.012_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.ajkd.2009.04.022","article-title":"The uremic retention solute p-cresyl sulfate and markers of endothelial damage","volume":"54","author":"Meijers","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cca.2016.03.012_bb0160","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2016.03.012_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-012-0258-1","article-title":"An update on uremic toxins","volume":"45","author":"Neirynck","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2016.03.012_bb0170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0175","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0180","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2005030310","article-title":"Removal of p-cresol sulfate by hemodialysis","volume":"16","author":"Martinez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2016.03.012_bb0185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0190","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin\u2013angiotensin\u2013aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2016.03.012_bb0195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2016.03.012_bb0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/gfs133","article-title":"p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells","volume":"28","author":"Sun","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2016.03.012_bb0210","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1093\/ndt\/gfs382","article-title":"p-Cresol, but not pcresylsulphate, disrupts endothelial progenitor cell function in vitro","volume":"27","author":"Zhu","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0215","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/ndt\/gfq251","article-title":"Serum proteinbound uraemic toxins and clinical outcomes in hemodialysis patients","volume":"25","author":"Lin","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2016.03.012_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijcard.2006.06.066","article-title":"Chronic kidney disease in patients with chronic heart failure\u2014impact on intracardiac conduction, diastolic function and prognosis","volume":"118","author":"Bruch","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2016.03.012_bb0225","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2013080899","article-title":"Longitudinal changes of cardiac structure and function in CKD (CASCADE study)","volume":"25","author":"Cai","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2016.03.012_bb0230","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000327131","article-title":"Does uremia cause vascular dysfunction?","volume":"34","author":"Brunet","year":"2011","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.cca.2016.03.012_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","article-title":"Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3\u20134 chronic kidney disease","volume":"45","author":"Rossi","year":"2014","journal-title":"Arch. Med. Res."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116300973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116300973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T10:30:20Z","timestamp":1718447420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116300973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":47,"alternative-id":["S0009898116300973"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.03.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations among chronic kidney disease, high total p-cresylsulfate and left ventricular systolic dysfunction","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}